The Global Molecular Diagnostics Market is expected to be around US$ 16.90 billion by 2028 and will grow at a CAGR of more than 9% in the given forecast period.
Molecular diagnostic tests are wont to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, etc. to further diagnose the disease. These are cumulative techniques for analysing biological markers at the molecular level, like genome and proteome. These techniques are used for diagnosis of the varied infectious diseases, cancer, etc. and is additionally wont to check the genetic predisposition to a disease.
The factors such growth within the prevalence of the infectious diseases and various sorts of cancer, rise in awareness and acceptance of personalized medicines, growth within the biomarker identification, and advancement in molecular diagnostics drive the market growth. Stringent regulatory requirements for the approval of latest molecular diagnostics techniques hampers the expansion of the market. Nevertheless, increase in adoption of the molecular diagnostics within the emerging economies provide growth opportunities for the market.
The global Molecular Diagnostics market is segregated on the basis of Product & Service as Reagents & Kits, Instruments, and Software and Service. Based on Technology the global Molecular Diagnostics market is segmented in Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and NGS, DNA Microarrays, In Situ Hybridization, and Other Technologies.
Based on Application, the global Molecular Diagnostics market is segmented in Infectious Disease, Oncology, Genetic Tests, and Other Applications. The report also bifurcates the global Molecular Diagnostics market based on End User in Hospital and Academic Laboratories, Reference Laboratories, and Other End-Users.
The global Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Roche Diagnostics, QIAGEN N.V., Hologic Inc, Abbott Laboratories, Grifols, Siemens Healthcare, Becton, Dickinson, Beckman Coulter Inc., bioMérieux SA, and others are among the major players in the global Molecular Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Molecular Diagnostics Market has been segmented as below:
Molecular Diagnostics Market, By Product & Service
Molecular Diagnostics Market, By Technology
Molecular Diagnostics Market, By Application
Molecular Diagnostics Market, By End User
Molecular Diagnostics Market, By Region
Molecular Diagnostics Market, By Company
The report covers:
Report Scope:
The global Molecular Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics.
The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Molecular Diagnostics market share. Major industry players with significant revenue share include Roche Diagnostics, QIAGEN N.V., Hologic Inc, Abbott Laboratories, Grifols, Siemens Healthcare, Becton, Dickinson, Beckman Coulter Inc., bioMérieux SA, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Medical Image Analysis Software Market
Healthcare Life Science & Chemical Instrumentation Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Molecular Diagnostics Market, By Product & Service
5.1 Introduction
5.2 Reagents & Kits
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Instruments
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Software and Service
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Molecular Diagnostics Market, By Technology
6.1 Introduction
6.2 Polymerase Chain Reaction (PCR)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 DNA Sequencing and NGS
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 DNA Microarrays
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 In Situ Hybridization
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Other Technologies
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Molecular Diagnostics Market, By Application
7.1 Introduction
7.2 Infectious Disease
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Oncology
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Genetic Tests
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other Applications
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Molecular Diagnostics Market, By End User
8.1 Introduction
8.2 Hospital and Academic Laboratories
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Reference Laboratories
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Other End-Users
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9. Molecular Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Molecular Diagnostics, By Product & Service
9.2.2 North America Molecular Diagnostics, By Technology
9.2.3 North America Molecular Diagnostics, By Application
9.2.4 North America Molecular Diagnostics, By End User
9.3 Europe
9.3.1 Europe Molecular Diagnostics, By Product & Service
9.3.2 Europe Molecular Diagnostics, By Technology
9.3.3 Europe Molecular Diagnostics, By Application
9.3.4 Europe Molecular Diagnostics, By End User
9.4 Asia-Pacific
9.4.1 Asia-Pacific Molecular Diagnostics, By Product & Service
9.4.2 Asia-Pacific Molecular Diagnostics, By Technology
9.4.3 Asia-Pacific Molecular Diagnostics, By Application
9.4.4 Asia-Pacific Molecular Diagnostics, By End User
9.5 Rest of the World
9.5.1 Rest of the World Molecular Diagnostics, By Product & Service
9.5.2 Rest of the World Molecular Diagnostics, By Technology
9.5.3 Rest of the World Molecular Diagnostics, By Application
9.5.4 Rest of the World Molecular Diagnostics, By End User
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
11.1 Roche Diagnostics
11.2 QIAGEN N.V.
11.3 Hologic Inc
11.4 Abbott Laboratories
11.5 Grifols
11.6 Siemens Healthcare
11.7 Becton
11.8 Dickinson
11.9 Beckman Coulter Inc.
11.10 bioMérieux SA
11.11 Danaher Corporation
The Molecular Diagnostics Market has been segmented as below:
Molecular Diagnostics Market, By Product & Service
Molecular Diagnostics Market, By Technology
Molecular Diagnostics Market, By Application
Molecular Diagnostics Market, By End User
Molecular Diagnostics Market, By Region
Molecular Diagnostics Market, By Company
